Procedural and follow-up outcomes among patients undergoing successful recanalisation of coronary chronic total occlusions using biolimus drug-eluting stents-Reference-Cited by-同舟云学术

Procedural and follow-up outcomes among patients undergoing successful recanalisation of coronary chronic total occlusions using biolimus drug-eluting stents

Published:2014-01-23 Issue:3 Volume:29 Page:216-220
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Saraf S.,Cockburn J.,Ferreira I.,Hopkins S.,Hildick-Smith D.

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12928-014-0243-y.pdf

Reference23 articles.

1. Windecker S, et al. Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. The Lancet. 2008;372:1163–73.

2. Barlis P, Regar E, Serruys PW, Dimopoulos K, Van der Giessen WJ, Van Geuns RJ, Ferrante G, Wandel SM, Windecker S, Van Es GA, Eerdmans P, Juni P, Di Mario C. An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study. Eur Heart J. 2010;2:165–76.

3. Wykrzykowska J, Serruys P, Vries TD, et al. Three year outcomes of chronic total occlusion treatment with biolimus eluting biodegradable polymer stent versus sirolimus eluting permanent polymer stent in the LEADERS all-comers trial. J Am Coll Cardiol. 2011;58:B75–6.

4. Grube E, Buellesfeld L. BioMatrix biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease. Expert Rev Med Devices. 2006;3:731–41.

5. Danzi G, Chevalier B, Urban B, Fath-Ordoubad F, Carrie D, Wiemer M, Serra A, Wijns W, Kala P, Stabile A, Ruigomez G, Laanmets P, Strupp G, West N, Paunovic D, on behalf of NOBORI 2 Investigators. Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 study. EuroIntervention. 2012;8:109–16.